Sign inJoin waitlistJoin the waitlist

William Gwin

Assistant Professor, Division of Hematology and Oncology, University of Washington School of Medicine · University of Washington School of Medicine

Credentials: · · ·

History

University of Washington School of Medicine
Present

Medical Oncology
2010–2012
Duke University Hospital
2009–2010
Internal Medicine
University of Washington-Seattle Campus
2006–2009
University of Alabama at Birmingham Marnix E. Heersink School of Medicine
2002–2006
Auburn University
1998–2002

Research

Vaccine Therapies for Cancer: Then and Now
Review · Targeted Oncology · 2021 · 167 citations
An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models
Breast Cancer Research · 2013 · 126 citations
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
Journal of Clinical Oncology · 2023 · 80 citations

Herbert Lyerly
11 papers
Michael Morse
10 papers
Hannah Linden
5 papers
MD
Mary Disis
5 papers
Natasha Hunter
5 papers
Jennifer Specht
4 papers
Nancy Davidson
4 papers
SV
Shaveta Vinayak
4 papers
Andrew Coveler
3 papers
John Liao
3 papers
NS
Neil Spector
3 papers
Barbara Goff
2 papers

Clinical trials

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
Principal investigator · Recruiting · Phase 2
University of Washington
2022–2027
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer
Principal investigator · Suspended · Phase 1
Veana Therapeutics
2020–2030